Stuart A. Arbuckle - 10 Aug 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, COO
Signature
/s/ Joy Liu, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
10 Aug 2022
Net transactions value
-$44,116
Form type
4
Filing time
12 Aug 2022, 16:05:59 UTC
Previous filing
10 Aug 2022
Next filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $9,956 +64 +0.1% $155.57 61,060 10 Aug 2022 Direct
transaction VRTX Common Stock Sale $51,355 -171 -0.28% $300.32 60,889 10 Aug 2022 Direct F1
transaction VRTX Common Stock Sale $2,718 -9 -0.01% $302.01 60,880 10 Aug 2022 Direct F1
holding VRTX Common Stock 140 10 Aug 2022 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -64 -0.96% $0.000000 6,571 10 Aug 2022 Common Stock 64 $155.57 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
F2 Fully vested.